打开APP

PLoS ONE:抑制NOX4酶治疗肝纤维化

  1. NOX4
  2. TGF-β
  3. 肝纤维化

来源:生物谷 2012-11-18 11:42

2012年11月7日 讯 /生物谷BIOON/ --近日,Bellvitge生物医学研究所研究人员完成的一项研究证实抑制NADPH氧化酶NOX4可以防止肝纤维化。相关研究论文发表在PLoS One杂志上。 研究人员研究了细胞因子转化生长因子-β(TGF-β)在肝脏病理过程中的功能。在纤维化过程中,TGF-β的水平增加,并伴随肝细胞死亡。

2012年11月7日 讯 /生物谷BIOON/ --近日,Bellvitge生物医学研究所研究人员完成的一项研究证实抑制NADPH氧化酶NOX4可以防止肝纤维化。相关研究论文发表在PLoS One杂志上。

研究人员研究了细胞因子转化生长因子-β(TGF-β)在肝脏病理过程中的功能。在纤维化过程中,TGF-β的水平增加,并伴随肝细胞死亡。TGF-β是一个复杂的细胞因子,在肿瘤形成的早期阶段,TGF-β是一个肿瘤抑制基因。

这项研究的目的是分析TGF-β信号途径可能是纤维化发生、细胞的活化和细胞外基质的生产和肝细胞死亡过程的关键通路。

早期研究已经证明,在体外和体内,抑制TGF-β将可能减少纤维化。然而,TGF-β是一种肿瘤抑制基因。抗TGF-β治疗肝纤维化患者是一个危险因素,因为这抑制了潜在的肿瘤抑制基因,在纤维化过程中,可能会诱发慢性肝损害和肝癌。

参与TGF-β信号通路的氧化酶NOX4无论是在体内还是在体外,都在纤维化中起着重要的作用。在纤维化实验模型小鼠中,抑制NOX4既能防止激活细胞外基质产生细胞和肝细胞死亡。研究还表明丙型肝炎病毒感染引起的肝纤维化患者在不同阶段,NOX4的水平是非常高的。目前已经开发出一些NOX4抑制剂药物,因此该研究证明了其临床应用前景,并揭示了它们是如何发挥作用来治疗肝纤维化患者的。(生物谷:Bioon.com)

NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development.

Sancho P, Mainez J, Crosas-Molist E, Roncero C, Fernández-Rodriguez CM, Pinedo F, Huber H, Eferl R, Mikulits W, Fabregat I.

A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2-/-/p19ARF-/-, Stat3Δhc/Mdr2-/-) and a model of experimental induced fibrosis (CCl4) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-β pathway activation. In vitro TGF-β-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-β is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-β-induced epithelial-mesenchymal transition (EMT), but was required for TGF-β-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-β-induced death of hepatocytes.

版权声明 本网站所有注明“来源:生物谷”或“来源:bioon”的文字、图片和音视频资料,版权均属于生物谷网站所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:生物谷”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。

87%用户都在用生物谷APP 随时阅读、评论、分享交流 请扫描二维码下载->